Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Antigens, Neoplasm
MeSH Descriptor Data 2026
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Antigens, Neoplasm
Tree Number(s)
D23.050.285
Unique ID
D000951
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000951
Annotation
coord IM with required neopl coords with
/immunol
(IM); Manual 24.4.4.1+
Scope Note
Newly formed
ANTIGENS
that arise from mutations in tumor cells. These antigens are specific to cancer cells and absent in normal tissues.
Entry Version
ANTIGENS NEOPL
Entry Term(s)
Neoantigens
Neoplasm Antigens
Tumor Antigen
Tumor Antigens
Registry Numbers
0
NLM Classification #
QW 573.5.N4
Previous Indexing
Antigens (1966-1972)
Neoplasms/immunology (1966-1972)
specific neoplasm/immunology (1966-1972)
Public MeSH Note
73
History Note
73
Date Introduced
1973/01/01
Last Updated
2026/01/01
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
analysis (AN)
biosynthesis (BI)
blood (BL)
cerebrospinal fluid (CF)
chemistry (CH)
classification (CL)
drug effects (DE)
economics (EC)
genetics (GE)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacology (PD)
physiology (PH)
poisoning (PO)
radiation effects (RE)
therapeutic use (TU)
toxicity (TO)
ultrastructure (UL)
urine (UR)
Biological Factors [D23]
Antigens [D23.050]
Allergens [D23.050.063]
Antigen-Antibody Complex [D23.050.101]
Antigens, Archaeal [D23.050.140]
Antigens, Bacterial [D23.050.161]
Antigens, Dermatophagoides [D23.050.181]
Antigens, Fungal [D23.050.202]
Antigens, Helminth [D23.050.223]
Antigens, Heterophile [D23.050.244]
Antigens, Neoplasm [D23.050.285]
CD24 Antigen [D23.050.285.018]
CD52 Antigen [D23.050.285.022]
Ki-1 Antigen [D23.050.285.025]
Basigin [D23.050.285.040]
Antigens, Tumor-Associated, Carbohydrate [D23.050.285.050]
Antigens, Viral, Tumor [D23.050.285.062]
Carbonic Anhydrase IX [D23.050.285.196]
Carcinoembryonic Antigen [D23.050.285.329]
Epithelial Cell Adhesion Molecule [D23.050.285.357]
Folate Receptor 1 [D23.050.285.384]
Melanoma-Specific Antigens [D23.050.285.439]
Neprilysin [D23.050.285.550]
Prostate-Specific Antigen [D23.050.285.625]
Pancreatitis-Associated Proteins [D23.050.285.733]
Tissue Polypeptide Antigen [D23.050.285.840]
Antigens, Nuclear [D23.050.290]
Antigens, Plant [D23.050.291]
Antigens, Protozoan [D23.050.293]
Antigens, Surface [D23.050.301]
Antigens, T-Independent [D23.050.324]
Antigens, Viral [D23.050.327]
Autoantigens [D23.050.422]
Epitopes [D23.050.550]
Isoantigens [D23.050.705]
Superantigens [D23.050.820]
Vaccines, Synthetic [D23.050.865]
Expand All
Collapse All
Antigens, Neoplasm
Preferred
Concept UI
M0001435
Registry Numbers
0
Scope Note
Newly formed
ANTIGENS
that arise from mutations in tumor cells. These antigens are specific to cancer cells and absent in normal tissues.
Terms
Antigens, Neoplasm
Preferred Term
Term UI
T002880
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1973)
Neoplasm Antigens
Term UI
T002879
Date
03/29/1974
LexicalTag
NON
ThesaurusID
UNK (19XX)
Tumor Antigens
Narrower
Concept UI
M0001436
Registry Numbers
0
Terms
Tumor Antigens
Preferred Term
Term UI
T002881
Date
03/29/1974
LexicalTag
NON
ThesaurusID
UNK (19XX)
Tumor Antigen
Term UI
T001004486
Date
12/30/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
Neoantigens
Narrower
Concept UI
M000768948
Scope Note
Newly formed
ANTIGENS
arise from mutations in tumor cells. These antigens are specific to cancer cells and absent in normal tissues.
Terms
Neoantigens
Preferred Term
Term UI
T001148079
Date
04/14/2025
LexicalTag
NON
ThesaurusID
NLM (2025)
page delivered in 0.156s